Blockonomi

Quick Summary
Arm Holdings shares advanced approximately 5% during Monday’s session, reaching $330.97 as market participants shifted focus back to artificial intelligence and semiconductor stocks
Despite surging 121% year-over-year, the stock currently trades roughly 9.7% beneath its 20-day moving average following a recent correction
The company reports quarterly results on July 29, with analysts projecting earnings per share of 36 cents and revenue of $1.27 billion
Wall Street maintains a “Moderate Buy” consensus rating with 19 buy recommendations, 7 hold ratings, and 1 sell; the average target price stands at $279.83
Top-tier analysts from TD Cowen and UBS have set ambitious price objectives between $470 and $475, significantly exceeding consensus estimates
Arm Holdings (ARM) experienced a robust 5% advance on Monday, closing at $330.97, as market enthusiasm returned to artificial intelligence and semiconductor equities. The Nasdaq Composite climbed 1.41% during the session, providing tailwinds for chip-related names.
The stock has delivered impressive returns — posting a 121% gain over the trailing twelve months — though it has experienced notable consolidation since mid-June. Currently, shares trade approximately 9.7% under their 20-day simple moving average of $360.16.
The 50-day moving average rests at $301.29, establishing a critical support zone near $298.50. This level has previously attracted buying interest during recent declines, making it a crucial threshold for technical analysts to monitor.
A golden cross pattern that emerged in April continues to hold, which market technicians typically interpret as a constructive indicator for intermediate to long-term momentum.
The Relative Strength Index registers at 46.83 — firmly in neutral range. While the stock isn’t approaching overbought conditions, it also hasn’t established clear directional momentum following June’s retracement.
July 29 Earnings Report on the Horizon
Arm’s next quarterly earnings announcement is scheduled for July 29. Wall Street consensus calls for earnings per share of 36 cents, representing an increase from 35 cents in the comparable year-ago period. Revenue projections stand at $1.27 billion, up from $1.05 billion reported during the same quarter last year.
While these figures demonstrate consistent expansion, the stock’s price-to-earnings multiple of 370.9 suggests elevated expectations are already priced in. Any disappointment in results or forward guidance could trigger significant downside pressure.
ARM’s most recent quarterly performance delivered $0.60 in earnings per share on $1.49 billion in revenue, achieving a net profit margin of 18.37%.
Analyst Sentiment and Price Targets
The Street maintains a “Moderate Buy” consensus based on 27 analyst ratings — breaking down to 19 buy recommendations, 7 hold ratings, and 1 sell. The mean 12-month price objective stands at $279.83, notably below current trading levels.
More optimistic Wall Street firms paint a bullish picture. TD Cowen reaffirmed its Buy stance on June 24, elevating its price target to $475. UBS echoed this sentiment, raising its objective to $470 on the same date. Bank of America maintained its Neutral rating while increasing its target to $460.
Conversely, New Street Research downgraded Arm from Buy to Neutral on June 18, expressing concerns about stretched valuation metrics. Several analysts have cautioned that share prices have outpaced underlying business fundamentals, and potential selling pressure from SoftBank could present challenges.
Insider activity has tilted toward selling. During the previous three months, company insiders disposed of 248,205 shares valued at approximately $57.7 million.
Recent developments include Oracle Cloud Infrastructure joining ARM’s AGI CPU ecosystem, broadening the company’s presence in agentic AI applications and data center computing. Nvidia recently introduced an ARM-based laptop processor, further demonstrating the architecture’s expanding market penetration.
Institutional investors hold 7.53% of outstanding shares, with multiple new positions established during Q1 and Q2 2026.
With a beta coefficient of 3.76, ARM exhibits significant volatility relative to broader market movements. The 52-week trading range spans from $100.02 to $452.70.
Investors will turn their attention to the July 29 earnings release as the next major market-moving event.
The post Arm Holdings (ARM) Stock Surges 5% Amid Semiconductor Sector Rebound appeared first on Blockonomi.

Key Highlights
PANW reached a record peak of $358.31 on July 6, 2026
Year-to-date gains stand at 94%, with a 77% increase over 12 months
The stock has surged 32% since mid-June, powered by AI-driven cybersecurity needs
CNBC’s Jim Cramer endorsed PANW as a buy in January 2026, praising CEO Nikesh Arora’s leadership
Multiple Wall Street firms including FBN Securities, Cantor Fitzgerald, and William Blair maintain optimistic outlooks
Palo Alto Networks stock climbed to an unprecedented high of $358.31 on July 6, 2026, marking a 2.71% gain for the session. The cybersecurity giant’s valuation now stands at $289 billion.
The stock has delivered remarkable returns this year, posting a 94% advance year-to-date. Looking back twelve months, shares have appreciated 77%, while the half-year performance shows an impressive 87% jump.
The momentum has been particularly strong in recent weeks. From June 10 through the current session, PANW has rocketed 32% higher.
This latest surge correlates with heightened enterprise investment in sophisticated cybersecurity solutions as artificial intelligence-enabled attacks grow increasingly sophisticated. Industry observers note that organizations are ramping up expenditures on platforms like Palo Alto Networks’ offerings as AI-powered threats become more elaborate and dangerous.
The journey hasn’t been without turbulence. On March 27, shares tumbled 6% following reports that AI systems — including technology from Anthropic — might be leveraged to identify software vulnerabilities, raising questions about the long-term outlook for cybersecurity firms.
However, the market’s concerns proved short-lived. The prevailing sentiment has since reversed dramatically: AI-related threats are now viewed as catalysts for increased cybersecurity investment rather than risks to security vendors.
Wall Street’s Perspective
The analyst community has embraced an overwhelmingly positive stance. FBN Securities lifted its price objective to $330 while maintaining its Outperform designation. Cantor Fitzgerald reaffirmed its Overweight rating alongside a $340 target, highlighting that both revenue and NGS ARR exceeded projections.
William Blair upgraded its fiscal 2026 free cash flow projection to $4,225 million, modeling a 37% free cash flow margin. This forecast aligns closely with the company’s own guidance regarding cash generation capabilities.
PANW’s latest quarterly results showed revenue surpassing consensus forecasts by 2%, representing an improvement compared to previous reporting periods.
It’s worth noting that InvestingPro analysis indicates the shares are presently trading above their Fair Value calculation, a consideration given the stock’s rapid appreciation.
Cramer’s Endorsement and Institutional Backing
In January 2026, CNBC personality Jim Cramer designated PANW as a buy opportunity, emphasizing CEO Nikesh Arora’s proven execution abilities. This represented a significant shift, as Cramer had previously maintained a more reserved stance on the security firm.
“Palo Alto’s a terrific company. I think it is a buy,” Cramer stated during his endorsement.
Brown Advisory’s Large-Cap Growth Strategy revealed a PANW holding in its first quarter 2026 shareholder communication. The investment firm disclosed that it established the position during a market weakness period triggered by AI disruption anxieties and concerns about acquisition integration challenges. Brown Advisory characterized these worries as exaggerated.
The investment manager emphasized Palo Alto Networks’ strategic emphasis on platform consolidation, where corporate customers aggregate multiple security products under a single vendor relationship, as a critical expansion opportunity. The fund also underscored robust free cash flow generation and dependable operational performance.
Shares are currently changing hands just 1% beneath the 52-week peak established during today’s trading session.
The post Palo Alto Networks (PANW) Stock Surges to New Peak as AI Security Concerns Drive Growth appeared first on Blockonomi.

Key Takeaways
GE Vernova reached a record peak of $1,182.31 on July 6, climbing 121.61% over 12 months and 70.6% since the start of 2026
Jim Cramer declared GEV his top pick in the power sector and disclosed it represents a “very big position” in his Charitable Trust portfolio
First quarter 2026 revenue reached $9.3 billion, marking a 16% year-over-year increase, while EPS of $1.98 surpassed analyst projections
The company secured $18.3 billion in orders during Q1, reflecting 71% organic growth, pushing total backlog to $163 billion
Management elevated 2026 free cash flow projections to $6.5–$7.5 billion from the previous range of $5.0–$5.5 billion
GE Vernova (GEV) established a fresh all-time peak at $1,182.31 on July 6, 2026, continuing its impressive ascent with shares hovering around $1,183 and commanding a market capitalization of $310.9 billion. This milestone caps a remarkable rally that has delivered more than 120% gains over the past twelve months.
Shares have surged 70.6% since January, positioning GEV among the energy sector’s top-performing equities. Such dramatic appreciation inevitably attracts scrutiny from market observers and institutional investors alike.
During the June 30 edition of Mad Money’s Lightning Round, Jim Cramer singled out GE Vernova as his preferred play in the power generation space. He revealed the stock occupies substantial real estate in his Charitable Trust holdings—a transparent, trackable stake rather than casual commentary.
“GE Vernova of those is my favorite. It’s one that the Charitable Trust has a very big position… I say still buy GE Vernova,” Cramer stated.
The endorsement came with shares already trading at elevated levels. GEV finished July 2 at $1,113.11, yet its three-year cumulative return of 867.92% demonstrates how dramatically the investment narrative has transformed.
First Quarter Results Validate Bullish Thesis
The company’s first quarter 2026 financial performance, disclosed April 22, provided concrete evidence supporting the optimistic outlook.
Topline revenue reached $9.3 billion, representing 16% year-over-year expansion. Earnings per share of $1.98 exceeded the Street’s $1.84 consensus by 7.6%.
Order momentum stole the spotlight. First quarter bookings totaled $18.3 billion, surging 71% on an organic basis, with robust contributions from Power, Wind, and Electrification divisions. The cumulative backlog swelled to $163 billion, expanding by $13 billion in just three months.
Free cash flow generation of $4.8 billion represented more than a fourfold increase from the prior year. Adjusted EBITDA nearly doubled to $0.9 billion, while margins widened 390 basis points to 9.6%.
CEO Scott Strazik highlighted accelerating demand for gas turbines. Gas Power equipment backlog and slot reservations expanded from 83 gigawatts to 100 gigawatts during the quarter. Management now aims to reach at least 110 gigawatts by the close of 2026.
Management Lifts Full-Year Projections
Following the strong quarterly performance, GEV elevated its full-year 2026 outlook across all primary financial metrics.
Revenue expectations now span $44.5–$45.5 billion. Adjusted EBITDA margin guidance increased to 12–14% from the prior 11–13% range. Free cash flow projections jumped significantly to $6.5–$7.5 billion versus the earlier $5.0–$5.5 billion target.
The company concluded Q1 holding $10.2 billion in cash and distributed $1.4 billion to shareholders via share repurchases and dividends.
Wall Street coverage has grown increasingly supportive. Bernstein launched coverage with an outperform recommendation. Jefferies boosted its price objective to $1,210 while reaffirming a Buy rating, citing a robust order book extending through 2031.
InvestingPro’s valuation model suggests the stock currently trades above its Fair Value calculation—an important consideration for investors contemplating entry points.
From a technical perspective, shares encountered resistance around the $1,170–$1,180 zone on July 2 before retracing. The 50-day, 100-day, and 200-day moving averages currently rest near $1,052, $959, and $794 respectively.
Second quarter 2026 results are scheduled for July 22. Analysts assign a Zacks Rank of 2 (Buy) accompanied by a positive Earnings ESP of 10.35%, with estimate revisions trending favorably ahead of the release.
The post GE Vernova (GEV) Stock Soars to Record High as Cramer Doubles Down on Position appeared first on Blockonomi.

Key Takeaways
MRNA reached a 52-week peak of $81.42, representing a 169.2% annual increase
Six-month performance shows a remarkable 124% climb
InvestingPro identifies the stock as trading above its Fair Value calculation
Wall Street analysts hold an average “Reduce” stance with a $37.13 mean target
Corporate insiders have offloaded 125,088 shares totaling more than $6.1 million over 90 days
Moderna shares peaked at $81.42 on July 6, establishing a fresh 52-week record and continuing what has become one of biotech’s most dramatic rallies this year. Trading hovered around $81.51 shortly thereafter, pushing the company’s market capitalization to approximately $32.2 billion.
The 52-week floor stands at $22.28. This positions MRNA with more than a triple-digit gain from its nadir — specifically, a 169.2% total return over twelve months.
The half-year climb alone registers at 124%, fueled partly by revitalized enthusiasm for Moderna’s mRNA technology and multiple developmental announcements.
During its Science Day presentation, Moderna disclosed that mRNA-6007, its in vivo CAR-T initiative, is advancing into preliminary development targeting autoimmune conditions, particularly systemic lupus erythematosus and related B cell-driven disorders.
Regulatory developments also contributed momentum. An FDA advisory panel delivered a unanimous endorsement for Moderna’s experimental seasonal influenza vaccine, mRNA-1010, for the 50-and-over demographic — representing a significant validation for the company’s expanding portfolio.
Options market participants responded actively. Contract volume reached 121,257, with substantial interest concentrated in the June 18, 2026 $65 call option.
Wall Street Remains Unconvinced
Notwithstanding the share price momentum, the analyst consensus tells a starkly different story. Moderna holds an aggregate rating of “Reduce” with a consensus price objective of merely $37.13 — representing less than 50% of current trading levels.
Goldman Sachs elevated its projection from $43 to $49 while maintaining a “neutral” stance. Bank of America adjusted upward from $32 to $34 but preserved an “underperform” rating. Barclays increased from $25 to $48 with “equal weight.” Both Jefferies and UBS maintained “hold” recommendations.
Among analysts tracking MRNA, two assign it a Buy rating, eleven suggest Hold, and five recommend Sell.
InvestingPro analytics position the equity among the platform’s most overextended securities when measured against its Fair Value assessment.
Corporate Leadership Reduces Positions
While institutional investors have been accumulating shares, company insiders have been liquidating positions. Board member Abbas Hussain divested 5,682 shares at $46.63 on May 1, trimming his holdings by 32%. Board member Noubar Afeyan sold 9,263 shares at $46.84 on May 21, decreasing his position by 70.24%.
Cumulatively, corporate insiders have liquidated 125,088 shares valued at more than $6.1 million during the previous 90-day period. Insider ownership currently represents 10.80% of outstanding shares.
Regarding institutional activity, the trend appears more constructive. Louisiana State Employees Retirement System established a fresh position of 17,700 shares valued at approximately $899,000 during Q1. AQR Capital, NewEdge Advisors, and American Century Companies similarly expanded their holdings. Institutional ownership now accounts for 75.33% of MRNA.
The company’s latest quarterly disclosure, published May 1, revealed Q1 revenue of $389 million — representing a 260.2% year-over-year expansion and significantly exceeding the $236.37 million analyst estimate. Earnings per share registered at -$3.40, falling short of the consensus forecast of -$3.02. The stock’s 50-day moving average currently sits at $53.50, while its 200-day average rests at $48.22.
The post Moderna (MRNA) Stock Surges 169% Despite Wall Street Skepticism appeared first on Blockonomi.

Key Takeaways
Rivian manufactured 12,613 vehicles and handed over 12,194 units in Q2 2026, surpassing its projection of 9,000–11,000 deliveries
Full-year 2026 delivery expectations were increased to 65,000–70,000 vehicles from the previous 62,000–67,000 range
Shares of RIVN climbed approximately 6% following the announcement, building on the prior week’s 10.2% increase
Investment firm Baird maintained its Outperform rating with a $23 price objective, suggesting about 23% potential upside
The quarterly performance benefited from EDV commercial van sales, R1 vehicle lineup, and initial R2 model shipments
Rivian (RIVN) is currently changing hands at $19.76, climbing roughly 6% on Monday, building momentum from the previous week’s 10.2% surge after the electric vehicle manufacturer reported quarterly delivery figures that substantially exceeded its own projections.
The automaker manufactured 12,613 units and completed deliveries of 12,194 vehicles throughout the three-month period concluded June 30. These numbers significantly outpaced Rivian’s internal projections of 9,000 to 11,000 deliveries.
Year-over-year delivery volume expanded by nearly 14%. The outperformance stemmed from robust demand for its electric commercial vans and R1 product line, combined with the commencement of R2 shipments — a development investors have been eagerly anticipating.
Let's talk about $RIVN, which is up ~10% today and ~30% in the last week…
The company had given Q2 delivery guidance of 9,000-11,000K vehicles. They ended up delivering 12,194!
And more importantly, they raised the full-year total from a guide of 62,000-67,000 to… pic.twitter.com/QAitkuGyr5
— Hamid (@hamids) July 2, 2026
In response to these results, Rivian elevated its full-year 2026 delivery projections to a range of 65,000 to 70,000 vehicles. This represents an increase from the previous bracket of 62,000 to 67,000 — marking a 3,000-vehicle boost at the median point.
This represents an unusual positive development for a company whose public market history has been characterized more by missed projections than exceeded expectations.
Wall Street Analysts Express Support
Baird confirmed its Outperform rating and maintained its $23.00 price objective after reviewing the delivery data. With current trading levels between $18.63 and $19.76, this target suggests potential appreciation of approximately 23%.
Canaccord and Needham similarly reaffirmed Buy ratings, contributing to the favorable analyst sentiment surrounding the stock this week.
Baird’s projection had represented the most optimistic forecast among Wall Street firms, and Rivian’s actual delivery number fell marginally short of it — though still exceeded the broader consensus. The firm adjusted its financial model to incorporate the Q2 results while maintaining its rating.
One concern analysts highlighted: Rivian’s gross profit margin currently stands at merely 1%, which continues to represent a significant challenge despite improving production volumes.
R2 Introduction Provides Growth Narrative
The second quarter represented the beginning of R2 deliveries. Although volumes remain modest, production acceleration is anticipated throughout the latter half of 2026.
The R2 represents a more compact, affordably-priced vehicle targeting a wider consumer audience compared to the R1 trucks and SUVs. Rivian has characterized it as the product capable of achieving meaningful production scale.
Commercial van shipments through the EDV initiative also bolstered quarterly performance. This business segment has demonstrated consistent results, despite receiving less market attention than the consumer vehicle division.
Visible Alpha analysts forecast Rivian will achieve 63,138 total vehicle deliveries for the complete year — modestly under the midpoint of the revised guidance range, indicating some Wall Street observers maintain cautious expectations regarding production acceleration.
Looking Ahead
Rivian plans to release complete Q2 2026 financial results on July 30, following market closure. A live audio presentation is scheduled for 5:00 p.m. ET to discuss operational performance and forward outlook.
RIVN has gained 1.8% year-to-date but remains 12% beneath its 52-week peak of $22.45, established in December 2025.
The post Rivian (RIVN) Stock Surges 6% Following Impressive Q2 Delivery Performance appeared first on Blockonomi.

Key Highlights
Belgian financial watchdog identifies six platforms lacking proper CASP credentials
European MiCA regulations enforce mandatory licensing requirements for crypto operators
Belgian authorities encourage platform verification through official registries
Identified providers added to official fraudulent operator warning database
Digital asset holders exposed to market volatility without standard compensation safeguards
Belgium’s financial regulatory authority has publicly identified six cryptocurrency service providers operating without proper authorization following the implementation of MiCA licensing requirements. The Financial Services and Markets Authority emphasized these entities are offering digital asset services without obtaining mandatory CASP credentials, issuing a clear advisory for Belgian residents to conduct thorough verification before engaging with any cryptocurrency platform.
Six Entities Identified for Unauthorized Operations
The Belgian supervisory body has specifically named Aurum Foundation, Bank Bit, Bithf Pro, Dxago, Global Dynamic Trade, and ZeriaFunding as entities conducting business within Belgian territory without proper regulatory clearance. These platforms have been incorporated into the authority’s official warning database for fraudulent CASP operations.
According to the regulatory body, MiCA legislation mandates that all cryptocurrency service providers obtain official authorization before conducting operations. Consequently, any organization wishing to provide digital asset services throughout Belgium or anywhere within the European Union must first acquire CASP designation. This regulatory framework encompasses activities including asset custody, exchange platforms, trading services, transfer facilities, advisory functions, and investment portfolio management.
The authority issued a stern recommendation discouraging public engagement with the identified entities. Citizens are strongly encouraged to cross-reference any potential provider against the authorized CASP registry maintained by regulators. The supervisory body acknowledged that its warning database cannot capture every unauthorized operator and continues to expand as new cases emerge.
Regulatory Framework Transitions Into Active Enforcement
The Markets in Crypto-Assets regulation became operational in late 2024, establishing unified cryptocurrency governance across European Union member states. This comprehensive framework outlined specific licensing pathways for both service providers and token issuers. Belgian authorities now implement this structure through national oversight mechanisms and public consumer advisories.
Cryptocurrency service providers entering the market after December 30, 2024, were required to secure CASP authorization immediately. Meanwhile, previously operating entities were granted a grace period that concluded on July 1, 2026. Following this date, any organization lacking proper authorization must cease all regulated cryptocurrency activities.
The Belgium advisory demonstrates the regulatory shift from framework development to active compliance enforcement. It illustrates how national authorities are actively identifying non-compliant operators beyond transitional deadlines. Cryptocurrency platforms must now demonstrate valid authorization credentials before soliciting Belgian consumers.
Financial Authority Emphasizes Market Dangers and Due Diligence
Belgium’s regulatory authority has also highlighted the substantial market dangers inherent in cryptocurrency investments. Digital asset valuations can experience dramatic fluctuations, while trading liquidity may evaporate during periods of market stress. Under such conditions, investors may find themselves unable to liquidate holdings at acceptable valuations or within desired timeframes.
The supervisory body also raised concerns regarding promotional activities conducted through social media channels. Certain marketing initiatives may present inaccurate, partial, or deliberately deceptive representations of cryptocurrency products. Belgium residents must therefore critically evaluate promotional content against verified regulatory documentation.
The authority further clarified that cryptocurrency losses fall outside traditional compensation schemes that protect certain conventional financial products. This reality intensifies individual responsibility for due diligence prior to account creation or capital deployment. For Belgian consumers, the regulatory message remains unambiguous: verify authorization credentials before entrusting funds to any cryptocurrency service provider.

The post Belgian Regulator Identifies Six Unlicensed Crypto Operators Following MiCA Enforcement appeared first on Blockonomi.

Key Highlights
Shares of AXT Inc (AXTI) climbed more than 19% Monday following the announcement of a strategic supply agreement with Coherent Corp (COHR).
The three-year deal involves AXT’s subsidiary AXT-Tongmei providing 6-inch indium phosphide wafer substrates to Coherent until June 2029.
The agreement includes a $22.3 million advance payment from Coherent to support capacity expansion at AXT’s Beijing manufacturing facility.
The contract includes performance clauses: failure by Coherent to meet minimum orders forfeits the prepayment, while AXT’s failure to meet capacity targets for six consecutive months allows Coherent to terminate and receive a refund.
Analysts maintain a Moderate Buy rating on AXTI with an average price target of $92.50.
Shares of AXT (AXTI) experienced a significant rally exceeding 19% Monday after the semiconductor substrate manufacturer announced a multi-year Master Development and Supply Agreement with Coherent (COHR).
The agreement, which became effective June 25, establishes a framework for AXT’s subsidiary AXT-Tongmei to deliver 6-inch indium phosphide (InP) wafer substrates to Coherent through the end of June 2029.
Central to this partnership is a substantial $22.3 million advance payment from Coherent. These funds are specifically designated to support AXT’s expansion of production capabilities at its Beijing manufacturing site during the 2026-2028 timeframe.
The advance payment structure allows Coherent to credit this amount against future wafer orders at predetermined pricing levels until the full prepayment is exhausted.
The agreement incorporates bilateral performance obligations. Should the contract terminate with remaining prepayment balance, Coherent maintains refund rights — provided it has satisfied its minimum purchase commitments.
Conversely, if Coherent doesn’t fulfill minimum order requirements, any remaining advance payment becomes non-refundable, and AXT gains termination rights.
Coherent retains a protective exit mechanism. Should AXT fail to achieve specified production capacity levels for a period exceeding six consecutive months, Coherent may withdraw from the agreement and reclaim any unutilized prepayment funds.
Agreement Specifications
Beyond the primary supply provisions, AXT has committed to providing Coherent with priority access to any additional manufacturing capacity developed beyond the agreed-upon baseline — maintaining identical pricing structures.
The partnership was formally disclosed through an 8-K filing submitted Thursday evening and incorporates conventional provisions addressing confidentiality obligations, force majeure circumstances, indemnification terms, and product warranties.
Indium phosphide wafer substrates serve critical functions in optical and telecommunications applications, positioning Coherent — a prominent industry participant in these sectors — as an ideal strategic partner for long-term collaboration.
COHR shares also responded positively to the announcement, advancing approximately 3.9% during Monday’s trading session.
AXTI’s Remarkable Performance
Monday’s price appreciation extends an already extraordinary performance trajectory for AXTI. Before today’s gains, the stock had already accumulated approximately 297% year-to-date returns and has skyrocketed more than 2,383% over the trailing twelve-month period.
Monday’s trading volume registered at approximately 2.6 million shares — notably below the three-month average volume of 9.39 million — indicating the substantial price movement occurred on comparatively modest trading activity.
The Coherent partnership represents one of multiple supply agreements AXT has recently finalized. The company previously announced a separate supply arrangement with Nanjing Casela Technologies scheduled for June 2026.
Wall Street analysts express measured optimism regarding AXTI’s prospects. The consensus recommendation stands at Moderate Buy, reflecting three Buy ratings and two Hold ratings issued within the past three months. The mean price target of $92.50 suggests potential upside of approximately 40% from current trading levels.
The post AXT Inc (AXTI) Stock Soars 19% Following $22.3M Coherent Supply Agreement appeared first on Blockonomi.

Key Highlights
Bernstein has elevated ASML’s price target from €1,700 to €2,300 while maintaining an “outperform” recommendation
AI-powered expansion in advanced logic and DRAM manufacturing underpins the bullish thesis
EUV equipment revenue projected to expand at 30% annually, reaching €42.7 billion in 2030
Total company revenue forecast at €80 billion by decade’s end, surpassing consensus by 24%
The firm simultaneously upgraded targets for TSMC, Intel, Micron, Samsung, and SK Hynix
Bernstein analysts have significantly increased their price objective for ASML Holding to €2,300 from €1,700, representing a substantial 35% increase, while reaffirming their “outperform” stance on the semiconductor equipment manufacturer.
This upward revision follows a substantial increase in the firm’s revenue projections for ASML, which analysts attribute to what they characterize as “unprecedented AI-driven expansion” across both cutting-edge logic processors and DRAM memory production.
ASML stock has experienced remarkable growth, more than doubling in value throughout the last year. Bernstein’s David Dai has identified the company as his preferred selection within the European semiconductor equipment sector.
The investment firm expanded its target valuation multiple to 40 times forward earnings from the previous 35 times, characterizing this as one standard deviation above historical averages.
Bernstein’s updated forecast for 2027 extreme ultraviolet lithography system deliveries, including next-generation High-NA equipment, now stands at 91 units compared to the prior estimate of 86. The 2028 projection jumped even more dramatically to 113 units from 87.
Dramatic Increase in EUV Revenue Projections
The investment firm now anticipates ASML’s EUV equipment revenue will expand at a 30% compound annual growth rate, climbing to €42.7 billion by 2030. This figure exceeds current market consensus by more than 30%.
Projections for deep ultraviolet systems have also been revised upward, with Bernstein forecasting €20 billion by 2030, compared to €13 billion expected in 2026.
In aggregate, Bernstein predicts ASML will achieve €80 billion in total revenue by 2030 — representing a 20% compound annual growth trajectory and standing 24% above the current market consensus of €64 billion.
Regarding profitability, Bernstein estimates 2028 earnings per share at €67, which they note sits 35% above consensus expectations, with 2030 EPS projected at €97, reflecting a 31% compound annual earnings growth rate.
The firm’s investment thesis emphasizes fundamental strength: while the stock price has doubled, earnings growth has kept pace. The valuation expansion isn’t driven by multiple inflation but by robust business performance.
Rollout Schedule for High-NA Technology
Bernstein outlined its anticipated adoption timeline for High-NA EUV systems across major chipmakers. Memory manufacturers are expected to lead implementation, benefiting from smaller DRAM die sizes that require only single mask exposure.
SK Hynix and Samsung are projected to integrate High-NA into DRAM manufacturing by 2027. Intel is expected to deploy the technology for logic chips in 2028, followed by Samsung’s logic implementation in 2029, with TSMC adopting in 2030.
Bernstein clarified that TSMC’s later adoption schedule doesn’t reflect diminished value proposition for the world’s leading foundry. Instead, analysts attribute the extended timeline to TSMC’s “prudence and conservativeness” when integrating novel manufacturing tools.
Lithography intensity — representing lithography’s proportion of total manufacturing expenses — is forecast to climb from 24% in 2025 to 26% in 2028, with DRAM production serving as the primary driver.
Bernstein concurrently raised price targets throughout the semiconductor industry: TSMC to $430 from $351, Intel to $100 from $65, Micron to $1,300 from $510, Samsung to 440,000 won from 225,000 won, and SK Hynix to 3,300,000 won from 1,150,000 won.
Potential headwinds identified by Bernstein include margin pressure from EUV commercialization expenses, inventory accumulation in China, weakness in the broader wafer fabrication equipment market, and additional export restrictions that could constrain sales to Chinese customers.
The post ASML Stock (ASML) Soars on Bernstein’s Bold €2,300 Price Target Upgrade appeared first on Blockonomi.

Key Highlights
SCLX shares climbed 10% following iHolding’s proposed $100M equity investment.
The term sheet values shares at $15 each, above current market prices.
Proposed capital aims to accelerate Scilex’s expansion, product rollout, and strategic deals.
Transaction requires due diligence, definitive documentation, and regulatory clearances.
Scilex highlighted the investment as backing for its non-opioid pain therapy initiatives.
Shares of Scilex Holding Company (SCLX) experienced significant upward movement following disclosure of a proposed $100 million common stock investment from iHolding Group LLP. The stock advanced 10.00% to reach $8.59, with intraday trading pushing above the $10 threshold during opening hours. While the stock retreated from its peak, it maintained solid gains and traded close to session highs heading into midday.
Scilex Holding Company, SCLX
SCLX Stock Gains Momentum Following Investment Announcement
Scilex disclosed that it has entered into a binding term sheet with iHolding Group LLP, a private investment firm headquartered in Almaty, Kazakhstan. The framework establishes terms for acquiring newly issued common stock in Scilex. The contemplated transaction amounts to $100 million and remains contingent on additional approvals and final documentation.
Under the proposed terms, iHolding would acquire shares at a price of $15.00 per share. This structure would translate to approximately 6.67 million newly issued shares. The proposed valuation significantly exceeds the stock’s midday trading range.
The disclosure provided fresh upward momentum for SCLX throughout the trading session. After an initial surge, shares experienced partial retracement before recovering. Market participants responded positively to the capital infusion blueprint.
Proposed Capital to Fuel Scilex Expansion Strategy
Scilex outlined plans to deploy the proposed proceeds toward multiple strategic objectives. The company identified product advancement, commercial launch activities, potential acquisitions, and collaborative partnerships as priority areas. Additional capital allocation would support operational expenses, working capital requirements, intellectual property development, and general corporate purposes.
Scilex specializes in non-opioid pain management solutions and complementary healthcare segments. The company’s portfolio addresses acute pain treatment, chronic pain management, neurodegenerative conditions, and cardiometabolic disorders. Consequently, the proposed financing would bolster both existing commercial initiatives and developmental pipeline activities.
Several contingencies must be satisfied before transaction completion. Both parties need to complete comprehensive due diligence and execute definitive legal documentation. Additional requirements include board of directors authorization, stockholder consent, and applicable regulatory approvals.
Central Asian Investment Group Expands Biotech Portfolio
iHolding characterized the proposed Scilex transaction as an element of its broader healthcare and biotechnology investment thesis. The organization concentrates on healthcare sectors, technology ventures, and cross-border strategic opportunities. It functions as a private investment platform operating from the Medeu District in Almaty.
The proposed arrangement aligns with Kazakhstan’s expanding emphasis on healthcare infrastructure and biotechnology advancement. iHolding targets pharmaceutical production capabilities, research initiatives, biotechnology innovation platforms, and global healthcare supply networks. Accordingly, the Scilex partnership could bridge U.S. biotechnology expertise with Central Asian healthcare development objectives.
Scilex positioned the proposed investment as a strategic catalyst for accelerated growth. The company emphasized that the arrangement remains subject to conditions and has not been finalized. Nevertheless, the disclosure generated positive market sentiment for SCLX stock, driven by the transaction’s scale and proposed share pricing.

The post Scilex Holding Company (SCLX) Stock Surges on $100M Investment Proposal from iHolding appeared first on Blockonomi.

Key Takeaways
Shares of WULF climbed 13.55% following news of a landmark Anthropic partnership valued at $19 billion.
The AI company will occupy TeraWulf’s 401 MW Justified Data facility located in Kentucky.
First phase deployment for Anthropic’s operations is scheduled for late 2027.
Divestiture of the Abernathy joint venture position frees up resources for wholly controlled projects.
Company realigns investment priorities toward fully owned AI data center assets.
Shares of TeraWulf Inc. experienced a significant rally on Monday as the company unveiled a transformative Anthropic partnership alongside a strategic portfolio restructuring. WULF climbed 13.55% to reach $24.05 during trading, following an initial spike before settling around the $24.00 mark. The dual announcements underscore TeraWulf’s accelerated transition from cryptocurrency mining infrastructure toward enterprise-scale AI data center operations.
TeraWulf Inc., WULF
Landmark Anthropic Agreement Establishes Revenue Foundation
TeraWulf formalized a two-decade lease arrangement with Anthropic covering its Justified Data facility in Hawesville, Kentucky. The contract is projected to deliver approximately $19 billion in guaranteed revenue throughout the initial lease period. This arrangement provides TeraWulf with predictable, long-horizon income anchored to specialized AI computing infrastructure.
The Justified Data site is designed to accommodate approximately 401 MW of critical information technology power load. Development will proceed through multiple phases, with TeraWulf targeting late 2027 for initial operational capacity. Complete build-out and full utilization are anticipated by the first quarter of 2028.
This partnership bolsters TeraWulf’s competitive standing in the AI data center sector. The company has prioritized securing reliable power supply, strategic campus development, and establishing direct enterprise relationships. Consequently, the Anthropic commitment validates its approach of maintaining ownership over infrastructure backed by extended contractual commitments.
Strategic Abernathy Divestiture Releases Growth Capital
TeraWulf simultaneously reached an agreement to divest its 50.1% ownership position in the Abernathy Joint Venture. A consortium spearheaded by Fluidstack, TeraWulf’s existing partner in the venture, will purchase the stake. The transaction monetizes TeraWulf’s approximately $450 million commitment at a valuation above invested capital.
The Abernathy Joint Venture launched in 2025 to construct a 168 MW AI-focused data center facility in Texas. TeraWulf collaborated with Fluidstack to progress the site through early development milestones. Following transaction completion, Fluidstack will assume full operational leadership of the Abernathy campus.
Proceeds from this sale equip TeraWulf with fresh capital for deployment into infrastructure assets under complete company ownership. The divestiture also streamlines corporate structure by eliminating joint venture reporting complexities from future financial statements. Accordingly, TeraWulf gains enhanced focus on properties where it maintains direct operational authority and customer engagement.
Company Refines Focus on Owned AI Assets
TeraWulf originally established operations centered on vertically integrated digital infrastructure paired with energy-efficient computing facilities. Surging artificial intelligence demand has driven the company toward larger-scale data center projects. The Anthropic lease now provides substantial commercial validation for this strategic direction.
Management indicated that both transactions enhance forward revenue predictability while reinforcing the company’s balance sheet. The moves concentrate capital on platforms where TeraWulf retains full ownership rights and operational oversight. Furthermore, these strategic shifts advance the company’s objective of generating sustainable cash flows from AI-focused infrastructure.
The market’s enthusiastic response to WULF stock reflects strong investor confidence in the company’s repositioned AI growth trajectory. The $19 billion Anthropic commitment establishes a substantial long-term revenue foundation. Simultaneously, capital unlocked through the Abernathy transaction positions TeraWulf to accelerate development of additional wholly owned AI campus properties.

The post TeraWulf (WULF) Stock Jumps 13% on Massive Anthropic Partnership and Strategic Pivot appeared first on Blockonomi.

Key Takeaways
NBIS shares advanced nearly 3% during Monday’s premarket session, reaching $222.00
The stock has delivered a 124.1% return over the last six months, crushing the S&P 500’s 8.9% advance
First-quarter 2026 revenue reached $399 million, representing a 684% year-over-year jump
The company increased its 2026 capital expenditure outlook to a range of $20B–$25B to support expanding infrastructure
Analysts maintain a consensus Buy recommendation with an average target of $213.89
Shares of Nebius Group (NBIS) advanced nearly 3% during Monday’s premarket hours, hitting $222.00, as capital flowed back into high-momentum artificial intelligence infrastructure plays. Broader market strength supported the move, with Nasdaq futures climbing 1.22% and S&P 500 futures rising 0.42%.
Over the past half-year, the stock has delivered an impressive 124.1% return, significantly outperforming the S&P 500’s 8.9% advance and the Zacks Computer & Technology sector’s 13.2% climb. During this same timeframe, Microsoft declined 18.9% while CoreWeave managed only a 5.9% gain.
Monday’s upward movement follows a retreat from NBIS’s 52-week peak of $299.86, reached in June. Currently trading 11.1% beneath its 20-day moving average of $249.11, the stock appears to be staging a recovery rather than initiating a fresh breakout.
From a technical perspective, NBIS is positioned above both its 50-day simple moving average of $215.09 and its 200-day SMA of $132.94. Key resistance is located near $233.50, while support holds around $200.50. The MACD indicator remains below its signal line, suggesting momentum traders should exercise caution.
First Quarter Delivers Explosive Growth
The first quarter of 2026 showcased exceptional performance. Total group revenues soared 684% year-over-year to reach $399 million. The Nebius AI division alone expanded 841% and achieved an annualized revenue run-rate of $1.9 billion.
Adjusted EBITDA margin for the entire group registered at 32%, while the Nebius AI segment delivered an impressive 45% margin. The company’s financial position was significantly strengthened through a $4.3 billion convertible note issuance and a $2 billion equity injection from NVIDIA.
Cash and cash equivalents currently total $9.3 billion. Leadership reaffirmed 2026 projections for group revenues between $3B and $3.4B, with annualized run-rate revenues expected to reach $7B–$9B and an adjusted EBITDA margin hovering around 40%.
Contracted power capacity expanded from 2 gigawatts to more than 3.5 GW during Q1, with plans to reach 4 GW by year’s end. An additional Pennsylvania facility will contribute another 1.2 GW once fully online.
Capital Spending Increases, Near-Term Margin Pressure Expected
Nebius elevated its 2026 capital expenditure forecast to $20B–$25B, up from the prior range of $16B–$20B. Leadership indicated the increased investment will support 2027 infrastructure expansion already secured through customer agreements.
Profitability metrics are anticipated to soften in the second quarter as capacity investments hit the books before corresponding revenue materializes. Margins should bounce back to Q1 levels in the third quarter and continue improving in Q4.
Pipeline development surged 3.5 times sequentially in the first quarter. Customer demand continues to exceed available infrastructure, with clients increasingly offering advance payments to lock in future GPU availability.
Regarding valuation, NBIS currently trades at a price-to-book ratio of 7.53x compared to the industry benchmark of 3.91x. The company’s next earnings report is scheduled for August 6, with analyst consensus calling for a 73-cent per-share loss and $576.67 million in revenue.
Bank of America maintains a Buy rating with a $280 target. BNP Paribas launched coverage with a Neutral stance at $255. DA Davidson holds a Neutral rating with a $250 target. The average analyst price target stands at $213.89, trailing the current trading price.
Zacks has assigned NBIS a Hold rating (Rank #3).
The post Nebius (NBIS) Stock Climbs 3% on AI Infrastructure Momentum – Is It a Buy? appeared first on Blockonomi.

Key Takeaways
TF Securities analyst Ming-Chi Kuo projects a Q4 2026 foldable iPhone launch, with constrained Q3 shipments of just 500K–1M devices
H2 2026 foldable iPhone shipments projected at 7–8 million total units
Expected pricing of $2,300–$2,500 won’t deter buyers, according to Kuo’s sellout forecast
AAPL climbed 0.1% to $309 on Monday; Jefferies warns stock could remain “range-bound” short-term
Analyst consensus leans “Moderate Buy” with a $314.85 average target price
Apple’s long-awaited foldable iPhone is generating massive anticipation across the tech world, but supply constraints may leave eager buyers waiting months for delivery.
According to Kuo, Apple’s foldable “iPhone Ultra” could follow the iPhone X launch strategy
> Announced alongside the iPhone 18 Pro lineup
> Pre-orders may slip to late October
> Sales could begin in early November due to limited supply
> Apple reportedly expects only 7–8M… pic.twitter.com/3QP25fYDgp
— apple files (@applefiles_) July 5, 2026
Ming-Chi Kuo from TF International Securities indicated over the weekend that while Apple may reveal its foldable device during its fall product event, actual preorders and retail availability might slip into Q4 2026 as production ramps up gradually.
Shares of Apple were changing hands at $309 during Monday trading, posting a modest 0.1% gain following Thursday’s impressive 4.8% surge. The tech giant’s stock continues hovering close to its 52-week peak of $317.40.
According to Kuo’s projections, Apple will ship approximately 7 to 8 million foldable iPhones during the latter half of 2026. However, only a fraction of those units—between 500,000 and 1 million—will arrive during the third quarter.
This creates an extraordinarily narrow supply channel for what analysts anticipate will be overwhelming consumer interest.
“The foldable iPhone could sell out immediately after preorders open, with delivery lead times quickly stretching 4–6 weeks or longer and remaining there through December,” Kuo noted in his analysis.
While the anticipated $2,300 to $2,500 price range represents a significant premium, Kuo believes demand will remain strong regardless. He anticipates healthy sales momentum even at these elevated price points.
Kuo referenced Apple’s strategic approach during the iPhone X debut in 2017, when the company deliberately managed a phased rollout to generate excitement before expanding manufacturing capacity. The foldable device strategy appears to mirror that calculated methodology.
Market Dynamics and Investor Focus
For market participants, the critical evaluation period arrives later in the cycle. Kuo emphasizes that late 2026 through early 2027 will provide the clearest picture of “true demand” for the foldable model, after initial launch enthusiasm subsides and availability normalizes.
Jefferies cautioned Monday that AAPL shares might remain “potentially range-bound” in the near term, citing uncertainty around broader product demand patterns ahead of the new launch window.
Apple’s most recent quarterly results delivered earnings per share of $2.01, surpassing the $1.95 Street estimate, with revenues reaching $111.18 billion—reflecting 16.6% year-over-year growth. The company simultaneously increased its quarterly dividend from $0.26 to $0.27 per share.
Wall Street and Institutional Positioning
Among institutional investors, Realta Investment Advisors expanded its Apple holdings by 3.0% during the first quarter, positioning AAPL as its top holding at 7.1% of the portfolio, valued at approximately $20.46 million.
Analyst coverage remains largely constructive. Maxim Group established a bullish $350 price objective, while Robert W. Baird set its target at $310. Meanwhile, DA Davidson and Rosenblatt maintained more conservative neutral ratings with targets of $270 and $276 respectively.
The Street’s aggregate view registers as “Moderate Buy” with a mean price target landing at $314.85.
Regarding insider transactions, CFO Kevan Parekh divested 1,534 shares during April at $275 per share, while insider Ben Borders sold 1,274 shares in May at $290.
Apple currently commands a market capitalization of $4.53 trillion, trading at a price-to-earnings multiple of 37.32.
The post Apple (AAPL) Stock: Could the Foldable iPhone Trigger a Major Rally in 2026? appeared first on Blockonomi.

Key Takeaways
Shares of Dell Technologies climbed over 8% Monday, reaching approximately $427.50 following President Trump’s public recommendation for Americans to purchase Dell computers
This marks the second instance in 2026 where Trump has publicly endorsed the computer manufacturer, with a similar recommendation in February producing a parallel market response
Financial disclosure documents reveal Trump acquired a minimum of $1 million in Dell shares during the first quarter of 2026, sparking debate over potential conflicts of interest
The company’s latest quarterly performance exceeded analyst projections significantly — reporting EPS of $4.86 compared to the $2.96 forecast, and revenue of $43.84 billion against the anticipated $35.74 billion
Analysts maintain a Moderate Buy rating on Dell stock with a consensus price target of $490.38
Shares of Dell Technologies (DELL) experienced a significant rally exceeding 8% during Monday’s trading session on July 7, climbing to an intraday peak of $427.50 after President Donald Trump encouraged Americans to purchase Dell computers during a White House media briefing.
The stock began trading at $395.19, marking an increase from the previous Friday’s closing price of $394.32, ultimately reaching a session peak of $428.29. This represented approximately a $33 gain from the prior trading day’s close.
The president’s remarks came as he commended Dell CEO Michael Dell for his participation in the Trump Accounts initiative — a recently launched program designed to provide eligible American children with tax-advantaged investment accounts featuring a $1,000 initial deposit from the U.S. Treasury.
BREAKING: Dell stock, $DELL, surges after President Trump says Michael Dell's donation to Trump Accounts will be "repaid" and urges people to buy the stock. pic.twitter.com/Se7gf8oArG
— The Kobeissi Letter (@KobeissiLetter) July 6, 2026
This represents Trump’s second public endorsement of Dell in 2026. A previous statement in February produced a similar upward movement in the stock price, establishing what appears to be an emerging trend.
Investors seeking magnified exposure drove the GraniteShares 2x Long DELL Daily ETF (DLLL) up approximately 17% to $24.15. The leveraged product had already demonstrated premarket activity before Trump’s statements became widely known.
Public financial disclosure records indicate that Trump acquired at least $1 million worth of Dell stock throughout the first quarter of 2026. The president has maintained that his investment portfolio is administered through blind and semi-blind trust structures, with his son Eric Trump reportedly handling financial oversight.
Critics contend that this arrangement creates potential ethical issues when the president publicly advocates for a stock in which he maintains a documented investment position.
Wall Street Outlook and Target Prices
The analyst community’s perspective on Dell leans predominantly positive. The stock maintains a Moderate Buy consensus rating with an average analyst price target of $490.38.
Mizuho elevated its price target from $435 to $500 in early June while maintaining an outperform rating. UBS currently holds a $700 price objective. Raymond James recently adjusted its stance from outperform to market perform, expressing concerns about current valuation levels.
Certain analysts have cautioned that Dell shares may have appreciated excessively following a roughly 241% increase over the trailing twelve months.
Financial Performance and Business Metrics
Dell’s latest quarterly earnings release on May 28 significantly surpassed Wall Street expectations. The technology giant reported earnings per share of $4.86 versus the consensus forecast of $2.96, while revenue reached $43.84 billion compared to estimates of $35.74 billion — representing an 87.5% year-over-year revenue increase.
The company disclosed an AI server backlog totaling $51.3 billion. Management established fiscal year 2027 EPS guidance at $17.90 and second quarter 2027 EPS guidance at $4.80.
Dell’s 52-week trading range extends from $110.22 to $469.47. The stock’s 50-day moving average currently stands at $332.26, while the 200-day moving average sits at $208.59.
World Investment Advisors expanded its Dell holdings by 103.6% during the first quarter, increasing its position to 24,800 shares valued at approximately $4.07 million according to its most recent SEC filing.
Company insiders have divested roughly $1.4 billion in Dell shares over the last 90 days. One director liquidated 175,901 shares on June 1 at an average selling price of $457.99.
Dell has announced a quarterly dividend distribution of $0.63 per share, scheduled for payment on July 31 to shareholders of record as of July 21.
The post Dell (DELL) Stock Soars 8% Following Trump’s Second Public Endorsement appeared first on Blockonomi.

Key Takeaways
JPMorgan recommends purchasing semiconductor stocks following weakness in early H2 2026
Semiconductor benchmark SOX declined 5.4% last week before rebounding 2.5% on Monday
Bank’s investment hierarchy places semiconductors above hyperscalers and AI-vulnerable sectors
JPMorgan maintains caution on software, business services, and media due to AI disruption concerns
Analysts anticipate expanded market breadth in second half, favoring small caps and global equities
Semiconductor equities experienced turbulence entering the latter half of 2026. The PHLX Semiconductor Sector Index (SOX) declined 5.4% throughout the abbreviated trading period ahead of Independence Day. This marked the benchmark’s consecutive second week of losses.
iShares Semiconductor ETF (SOXX)
However, analysts at JPMorgan view this recent downturn as an attractive entry point rather than cause for alarm.
In a client communication released Monday, JPMorgan strategist Mislav Matejka stated that the semiconductor growth cycle is far from reaching its zenith. He emphasized that substantial new production capacity won’t materialize until 2028 at the earliest.
Market action validated this optimistic stance. The SOX jumped 2.5% at Monday’s opening bell. The Nasdaq Composite climbed 0.7% in early trading as investor appetite for AI-linked chip manufacturers returned to Wall Street.
Multiple stocks that underperformed the previous week spearheaded Monday’s recovery. Applied Materials, Marvell, and Broadcom all registered gains. Memory chip manufacturers such as Western Digital, Seagate, and Sandisk also rallied, propelling the Roundhill Memory ETF upward by over 6.1%.
JPMorgan’s Cautionary Notes
Despite its optimistic semiconductor outlook, JPMorgan expresses greater reservation toward other AI-related investments.
According to Matejka, the firm’s investment ranking places “semis over hyperscalers over AI at risk plays.” The Magnificent Seven technology giants are “likely to see derating continuing on monetization fears,” he noted.
JPMorgan maintains a “fundamentally bearish” stance on sectors vulnerable to what it terms AI cannibalization. This category encompasses software, business services, and media companies. While tactical rebounds may occur during oversold conditions, the bank’s overarching perspective remains negative.
The underlying concern is that artificial intelligence applications are eroding revenues for these sectors rather than generating new growth opportunities.
Second Half 2026 Market Perspective
Beyond the semiconductor sector, JPMorgan anticipates global equity markets reaching new peaks during the year’s second half.
The bank cites robust earnings projections, moderating inflation trends, and conservative investor positioning as fundamental support factors.
Matejka also identified the resolution of Iran-related geopolitical tensions as a potential catalyst. He suggested that crude oil prices, inflation expectations, government bond yields, and central bank policy forecasts could all retreat from Q2 levels.
He further noted that artificial intelligence “is unlikely to be the only story in town” through year-end. Small-capitalization stocks, cyclical sectors, and international markets should all gain as market participation expands beyond technology leaders.
Stagflation concerns that dampened investor sentiment in recent months are projected to diminish, the strategist indicated.
JPMorgan’s core thesis is straightforward: Semiconductor stocks represent the optimal vehicle for artificial intelligence exposure currently. Alternative AI-related investments present elevated risk profiles.
The post JPMorgan Urges Investors to Seize Semiconductor Selloff Opportunity appeared first on Blockonomi.

Key Takeaways
Strategy liquidated 3,588 BTC worth approximately $216 million to meet dividend obligations and maintain cash balances.
MSTR shares declined 1.41% following an intraday dip under $96 per share.
STRC preferred shares fell beneath par value, creating challenges for future capital raises.
The company maintains 843,775 BTC following the recent Bitcoin disposal.
Analysts at Bernstein suggest compulsory Bitcoin liquidations are improbable for Strategy.
Shares of Strategy (MSTR) experienced downward pressure Monday following disclosure that the firm liquidated 3,588 Bitcoin to satisfy preferred dividend requirements and bolster its cash position. The stock closed at $99.35, representing a 1.41% decline, after touching lows beneath $96 during morning trading. This transaction represents a significant moment for CEO Michael Saylor’s Bitcoin-centric treasury approach.
Strategy Inc, MSTR
Company Executes Bitcoin Liquidation Under New Policy Framework
Strategy completed the Bitcoin disposal for roughly $216 million based on recent regulatory filings. This transaction brought the firm’s aggregate Bitcoin position down to 843,775 coins. The announcement followed shortly after Strategy implemented policy changes permitting Bitcoin sales to satisfy dividend payments.
Documents reveal the company executed two separate transactions during the period. Between Monday and Tuesday, Strategy sold 1,363 Bitcoin at an average realized price of $59,256 per coin. Subsequently, from Wednesday through Sunday, the firm disposed of an additional 2,225 Bitcoin at an average price of $60,773. Combined, these sales represented roughly 0.42% of Strategy’s entire Bitcoin treasury.
Strategy previously disclosed a modest 32 Bitcoin sale during early June. That transaction marked the company’s first documented Bitcoin disposal since executing a tax-loss harvesting strategy in 2022. The current sale, however, carries substantially greater magnitude and demonstrates expanded utilization of Bitcoin for liquidity management purposes.
Preferred Stock Challenges Compound Equity Concerns
Strategy allocated sale proceeds toward satisfying preferred stock dividend commitments while simultaneously replenishing its dollar-denominated reserves. According to July 5 disclosures, the company held $2.55 billion in U.S. dollar reserves. This figure matched the reserve level reported in filings dated June 29.
Management also increased the annual dividend yield on STRC preferred securities to 12%. During Monday’s pre-market session, STRC traded at $88.70, significantly below the intended $100 par value. When preferred shares trade beneath par, the company faces increased difficulty executing future capital raises through STRC issuances.
This development contributed additional downward momentum for MSTR shares, ending a five-session winning streak. The stock has suffered notable losses over the trailing month. Bitcoin was trading near $62,900 before U.S. markets opened Monday, following a weekend peak around $63,700.
Substantial Bitcoin Position Anchors Corporate Strategy
Despite recent disposals, Strategy maintains its position as the world’s largest corporate Bitcoin holder. The company reports a cost basis of $63.7 billion for its Bitcoin holdings, translating to approximately $75,476 per coin. With Bitcoin recently trading near $60,000, Strategy recorded an $8.32 billion digital asset impairment during the second quarter.
While predominantly unrealized, this loss demonstrates vulnerability to Bitcoin’s price volatility. Strategy’s BTC Monetization Program authorizes up to $1.25 billion in Bitcoin liquidations. According to company statements dated July 5, this authorization remained fully unutilized.
Bernstein analysts recently published research suggesting Strategy faces minimal risk of mandatory Bitcoin sales. Their assessment cited the company’s substantial liquidity reserves, adequate cash coverage, and manageable near-term debt obligations. Strategy’s next significant principal repayment, approximately $1 billion, isn’t scheduled until third quarter 2028.
The post Strategy (MSTR) Stock Drops After Selling 3,588 Bitcoin to Cover Dividend Payments appeared first on Blockonomi.

TLDR
Micron shares gained approximately 3% during Monday’s trading following a 14% decline across the previous five sessions
UBS’s Nicolas Gaudois characterizes the recent selloff as “likely temporary” while maintaining a $1,625 valuation
DDR memory pricing is expected by UBS to increase 32% in Q3 2026 and another 18% in Q4
The memory sector is anticipated to produce approximately $1.2 trillion in free cash flow during 2027
Analyst consensus leans Buy with a mean price objective of $1,542.05
Shares of Micron Technology (MU) advanced approximately 3% during Monday’s trading session, reaching around $1,003, following a challenging week that witnessed a 14% decline across five consecutive days. The broader technology sector provided support — Nasdaq futures climbed 1.21% while the iShares Semiconductor ETF (SOXX) surged more than 5% during the same period.
No specific trigger drove the previous week’s decline. Market observers attributed the weakness to broader technology sector anxiety rather than company-specific developments at Micron.
UBS analyst Nicolas Gaudois capitalized on the weakness to reinforce his optimistic position. He characterized the recent selloff as “likely temporary” while maintaining his $1,625 valuation target.
Gaudois noted that “fundamentals remain strong,” highlighting projections for the memory industry to produce nearly $1.2 trillion in free cash flow by the 2027 fiscal year.
The UBS analysis also emphasized the supply-demand imbalance in DRAM markets. UBS projects the market will experience undersupply conditions through at least Q2 2028, with bit demand expansion of 36.2% in 2027 substantially exceeding supply growth of 19.3%.
Regarding pricing dynamics, UBS now anticipates DDR memory prices will climb 32% quarter-over-quarter in Q3 2026, with an additional 18% increase expected in Q4.
Memory Pricing Dynamics Fuel Optimistic Outlook
These pricing projections form the foundation of the bullish thesis. Elevated memory pricing translates directly into improved margins for Micron, while AI infrastructure expansion drives demand that current supply capacity cannot satisfy.
Micron has appreciated approximately 242% year-to-date entering Monday’s session and has climbed nearly 700% across the trailing twelve months. Such dramatic gains make any correction appear significant, yet UBS interprets it as short-term volatility within a larger structural growth narrative.
Cantor Fitzgerald elevated its price objective to $2,000 on June 29, maintaining an Overweight recommendation. Barclays subsequently established its own $2,000 target on June 25, also with an Overweight rating.
The Street’s consensus recommendation stands at Buy, with a mean price target of $1,542.05 — considerably above current trading levels.
Technical Position and Upcoming Earnings Report
From a technical perspective, Micron maintains a solid position on extended timeframes. The shares trade 18.4% above the 50-day simple moving average of $852.09 and 127.1% above the 200-day simple moving average of $444.34.
In the near term, shares are positioned 3.3% below the 20-day simple moving average of $1,043.27, reflecting the recent weakness. The relative strength index registers 48.67 — indicating neutral momentum without oversold conditions.
Primary resistance appears around $1,089.50. Support has been established near $991.00.
Micron is scheduled to announce earnings on September 22, 2026. The Street anticipates EPS of $31.24, climbing from $3.03 in the comparable period, on revenue of $50.72 billion compared to $11.31 billion in the prior-year quarter.
The stock currently trades at 22.1 times forward earnings. According to Benzinga Edge metrics, Micron registers 99.62 on Momentum and 97.83 on Quality, although its Value score of 28.46 indicates the premium investors are accepting for growth potential.
The post Micron (MU) Stock Surges 3% After UBS Analyst Labels Recent Decline a Strategic Entry Point appeared first on Blockonomi.

Key Takeaways
Bank of America upgraded IBM’s price target to $330 from $315, keeping its Buy recommendation, suggesting approximately 14% potential upside
Five-star analyst Wamsi Mohan designated IBM as the “quantum leader” following his attendance at the Quantum Tech World Conference
Between October 2025 and April 2026, IBM contributed 781 research papers to ArXiv, over three times Google’s 231 submissions
BofA forecasts Q2 revenue reaching $18.0 billion with earnings per share of $3.03 ahead of July 22 results
The company boasts 30 consecutive years of dividend increases and currently trades at a PEG ratio of 0.27
International Business Machines is approaching its second quarter earnings release on July 22 with renewed Wall Street confidence. On July 6, Bank of America Securities lifted its price objective for IBM shares to $330 from the previous $315, maintaining its Buy recommendation. With IBM trading at $289.52 at that time, the updated target represents approximately 14% potential appreciation.
The revised outlook originated from top-ranked analyst Wamsi Mohan, who recently participated in the Quantum Tech World Conference. His assessment positioned IBM as the undisputed “leader in the quantum category.”
The technology giant faces competition in quantum computing from companies including Rigetti, IonQ, D-Wave, recently public Xanadu, and Alphabet’s Google division. According to Mohan’s analysis, IBM maintains a significant advantage over these rivals.
Mohan evaluates IBM’s quantum advancement using three key indicators: programmable qubits, qubit operations, and throughput — which respectively measure problem complexity capabilities, system reliability, and computational speed.
Regarding research output, IBM produced 781 ArXiv publications from October 2025 through April 2026. This substantially exceeded Xanadu’s 260 papers and Google’s 231 contributions — establishing a decisive research leadership position.
IBM’s Quantum Security Initiative
IBM extends beyond quantum computer development to address the cybersecurity challenges these systems will create. The company’s Guardian Cryptography Manager solution assists organizations in identifying encryption protocols susceptible to potential quantum-powered attacks.
Mohan observed that practical quantum applications outside cryptography and simulation remain somewhat constrained. However, IBM has provided developers with cloud-based access to its quantum infrastructure, accelerating software innovation.
BofA’s Q2 Projections
Bank of America anticipates second quarter revenue of $18.0 billion with earnings per share reaching $3.03, including a pre-tax income margin expansion of 50 basis points versus previous periods. The analysis expects Confluent to generate $340 million during the quarter, representing roughly 5% of software segment growth.
Mohan views Q2 as a pivotal period — one that establishes momentum for the latter half of 2026, featuring improved software composition and initial gains in transaction processing linked to the z17 mainframe refresh cycle.
Bank of America also predicts IBM will elevate its full-year 2026 projections for both revenue and free cash flow when it announces results on July 22.
IBM currently trades at a price-to-earnings multiple of 25.48 and a PEG ratio of 0.27 — metrics indicating the stock remains attractively valued relative to its growth trajectory.
The aggregate analyst consensus on TipRanks stands at Moderate Buy, comprising 12 Buy recommendations and 5 Hold ratings. The mean price target across all covering analysts reaches $302.06, implying 4.3% upside potential.
The technology veteran has increased its dividend payout for 30 straight years, and recently extended the maturity terms on its $2.5 billion and $7.5 billion credit facilities by one year.
IBM also unveiled a breakthrough sub-1 nanometer semiconductor with a 0.7nm transistor architecture, integrating nearly 100 billion transistors on a fingernail-sized chip surface.
The post International Business Machines (IBM) Stock: Bank of America Boosts Target to $330, Cites Quantum Dominance appeared first on Blockonomi.

Key Points
Meta Platforms shares advanced 1.4% during pre-market hours on July 6 following Thursday’s downturn
Mark Zuckerberg acknowledged that AI agent advancement hasn’t matched expectations during the previous four months
The company intends to establish a cloud services division to monetize surplus AI computational resources
Quarterly revenue surged 33% to reach $56.3 billion, powered by increased advertising impressions and pricing
The next earnings report is slated for July 29, 2026
Shares of Meta Platforms (META) advanced 1.4% during pre-market hours on July 6, showing signs of recovery following Thursday’s significant decline. The stock was hovering near the $585–$586 range.
The previous day’s selloff was triggered by remarks CEO Mark Zuckerberg made during an internal company meeting, where he acknowledged that the development of AI agent technology “hasn’t really accelerated in the way that we expected” during the preceding four-month period. He further noted that the organization’s recent internal reorganization had yet to deliver the outcomes management anticipated.
Nevertheless, Zuckerberg expressed optimism to employees that AI-related investments would yield more substantial returns in the coming three to six months.
Cloud Computing Initiative Provides Fresh Investment Narrative
The morning recovery received support from cloud infrastructure news revealed earlier this week. Meta is reportedly building a cloud services division designed to monetize underutilized AI computing power — a strategy that may involve providing external parties access to artificial intelligence models running on the company’s proprietary infrastructure.
Evercore’s Mark Mahaney noted that Meta probably won’t challenge established cloud giants such as Amazon, Microsoft, or Alphabet head-on. He anticipates the company will pursue a strategy more aligned with emerging neocloud providers like CoreWeave and Nebius, which specialize in AI-focused computing solutions.
This cloud initiative carries significance because it repositions Meta’s substantial data center investments. Instead of appearing as expenses with ambiguous payoffs, that infrastructure could transform into a revenue-generating asset.
SpaceX has executed a comparable strategy — leasing surplus computing resources to market participants at attractive pricing.
Fundamental Business Performance Stays Strong
Meta’s core operations continue to demonstrate strength. During the most recent quarter, revenue expanded 33% compared to the prior year, reaching $56.3 billion. Advertising impressions increased 19% while average pricing per advertisement rose 12%.
These improvements stem partially from AI-enhanced recommendation systems that extend user engagement on Meta’s platforms and enable advertisers to more effectively target and convert potential customers.
Despite this robust expansion, META currently trades at a forward price-to-earnings multiple of merely 18 times current-year analyst projections — a modest valuation for an organization experiencing such growth rates.
The stock has retreated from its 52-week peak of $796.25 and presently trades nearer the bottom portion of its yearly range spanning $520.26 to $796.25.
Broader market dynamics present a complicated picture. The Nasdaq Composite declined 0.8% on July 6 while the Dow Jones advanced 1.1%, indicating investor rotation away from technology and growth-oriented equities.
Meta additionally confronts renewed regulatory challenges. India’s authorities issued their second warning within a week, insisting the company eliminate child exploitation material from its services.
The upcoming critical milestone arrives on July 29, when Meta delivers its quarterly financial results. Market participants will scrutinize any updates regarding AI advancement, cloud revenue projections, and infrastructure expenditure plans.
The post Meta Platforms (META) Stock Gains Momentum on Cloud Infrastructure Strategy appeared first on Blockonomi.

TLDR
Strategy disclosed an $8.32 billion quarterly loss on its digital asset portfolio for Q2 2026
A total of 3,588 Bitcoin were liquidated — 1,363 BTC sold June 29–30 and 2,225 BTC sold July 1–5
Sales occurred below the company’s average acquisition cost of $75,476 per Bitcoin
MSTR shares declined as much as 4.5% to $96.29 following the disclosure
Sale proceeds were allocated toward preferred stock dividend payments and bolstering the company’s cash reserves, which reached $2.55 billion by Sunday
Strategy (MSTR) shares tumbled up to 4.5% to $96.29 on Monday morning following the company’s disclosure of an $8.32 billion digital asset loss during its second quarter, alongside confirmation of recent Bitcoin liquidations.
Shares had rallied 7.9% at Thursday’s close. On Sunday, Chairman Michael Saylor shared a social media post displaying the company’s Bitcoin acquisition timeline, temporarily boosting investor sentiment before the regulatory filing was released.
MSTR was changing hands near $99.81, down 0.9%, prior to the full loss announcement. By Friday’s closing bell, the stock had surrendered approximately one-third of its value year-to-date in 2026.
Strategy has sold 3,588 $BTC for $216 million to fund dividends on our Digital Credit securities. As of 7/5/2026, we hodl ₿843,775 in our BTC Reserves and $2.55 billion in our USD Reserves. https://t.co/Cssgz29Psj
— Michael Saylor (@saylor) July 6, 2026
Bitcoin (BTCUSD) declined 1.34% on Monday. The digital currency has retreated roughly 30% from its April 2025 highs.
Strategy liquidated 1,363 Bitcoin during the June 29–30 period at an average sale price of $59,256 per coin, generating $80.8 million. Subsequently, another 2,225 Bitcoin were sold between July 1 and July 5 at an average price of $60,773, yielding $135.2 million.
In total, 3,588 Bitcoin were offloaded within seven days, all transacted below the firm’s average purchase price of $75,476 per unit.
Strategy currently maintains a position of 843,775 Bitcoin, originally acquired at an average cost of approximately $75,476 each.
Why Strategy Sold
According to the company, revenue from the Bitcoin liquidations was designated for funding preferred stock distributions and replenishing its United States dollar cash position.
Strategy keeps this USD reserve to service preferred stock dividends and interest obligations on existing debt. The reserve balance stood at $2.55 billion as of Sunday.
These sales followed a comprehensive financial restructuring initiative that Strategy unveiled on June 29, designed to shore up business stability and restore investor confidence.
Market Reaction
Coinbase Global (COIN) edged down 0.4% on Monday, whereas Robinhood Markets (HOOD) climbed 2.1%.
The Q2 impairment of $8.32 billion represents one of the company’s most substantial digital asset write-downs on record. The loss stems directly from disposing of Bitcoin at prices below original acquisition costs.
Strategy’s USD cash reserve totaled $2.55 billion as of Sunday, July 6.
The post Strategy (MSTR) Stock Drops 4.5% Following $8.3B Digital Asset Loss and Bitcoin Liquidation appeared first on Blockonomi.

Key Takeaways
American Bitcoin Corp (ABTC) implemented a 1-for-15 reverse stock split on July 2 to meet Nasdaq’s listing requirements
Shares touched a 52-week low of $8.00 and now trade at $7.70 — representing a 91% decline since the SPAC debut
Outstanding shares decreased from 1.09 billion to approximately 73 million post-split
First quarter 2026 revenue totaled $62.1 million, marking a 20.7% quarterly decline attributed to Bitcoin’s price weakness
Despite revenue headwinds, ABTC preserved gross margins above 50% by lowering mining costs per Bitcoin by 23%
American Bitcoin Corp (ABTC) commenced split-adjusted trading on July 6 after completing a 1-for-15 reverse stock split on July 2. While shares were anticipated to open at $8.40, they’ve tumbled to $7.70 — trading beneath the adjusted opening level.
The reverse consolidation served as a strategic maneuver to comply with Nasdaq’s mandatory $1.00 minimum bid price rule. Prior to the split implementation, ABTC traded at $0.56, placing the company in jeopardy of exchange delisting.
This corporate action compressed ABTC’s outstanding share base from roughly 1.09 billion shares to approximately 73 million. Although it addresses the immediate compliance issue, reverse splits typically receive skeptical reception from market participants.
Investors generally view them as superficial remedies — artificially inflating share prices without resolving underlying fundamental weaknesses.
ABTC has plummeted approximately 91% from its initial public listing through a SPAC transaction completed last September. With a 52-week peak of $153.60, the present $7.70 valuation represents a dramatic deterioration.
The firm currently maintains a market capitalization of $6.36 billion.
Q1 Financial Performance Shows Strain
The company’s first quarter 2026 financial results revealed revenue of $62.1 million, representing a 20.7% sequential decline. The downturn stemmed primarily from weakening Bitcoin valuations, which directly correlate with mining profitability.
Bitcoin retreated from its all-time peak of $126,000 last October to approximately $58,000 by June. Such severe price volatility creates significant headwinds for cryptocurrency mining operations.
From an operational efficiency standpoint, ABTC successfully reduced its per-Bitcoin mining expense by 23%, enabling the company to sustain gross profit margins exceeding 50%. This represents solid execution despite challenging market conditions.
The earnings release generated no analyst rating adjustments.
Technical Indicators Show Oversold Conditions — Valuation Concerns Persist
Based on InvestingPro’s technical evaluation, ABTC’s Relative Strength Index has entered oversold territory. This condition may attract short-term traders seeking potential mean reversion opportunities.
Nevertheless, the platform’s Fair Value assessment indicates the shares remain elevated relative to fundamental valuations even at current depressed levels. This presents a conflicting signal for potential investors.
Controlling Shareholder Outperforms Dramatically
ABTC operates as a majority-controlled subsidiary of Canadian mining entity Hut 8 (HUT), which established the venture alongside Eric Trump. Hut 8 has experienced dramatically superior performance — HUT shares have surged 344% during the trailing twelve months, presently quoted at $97.14.
American Bitcoin conducts industrial-scale cryptocurrency mining operations while simultaneously implementing a Bitcoin treasury strategy as a fundamental component of its business model.
As of July 6, ABTC trades at $7.70 compared to its 52-week zenith of $153.60, with the reverse split now operational and shares already declining below the anticipated post-split debut price of $8.40.
The post American Bitcoin (ABTC) Stock Plunges 91% Following 1-for-15 Reverse Split appeared first on Blockonomi.